These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 32030498)
21. Prevalence of heart failure phenotypes and current use of therapies in primary care: results from a nationwide study. Jensen J; Poulsen MK; Petersen PW; Gerdes B; Rossing K; Schou M ESC Heart Fail; 2023 Jun; 10(3):1745-1756. PubMed ID: 36852608 [TBL] [Abstract][Full Text] [Related]
22. A Stepwise Approach to the Management of Heart Failure and its Comorbidities. Rogers FJ; Saghir Z J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768 [TBL] [Abstract][Full Text] [Related]
23. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure. Greene SJ; Ayodele I; Pierce JB; Khan MS; Lewsey SC; Yancy CW; Alhanti B; Van Spall HGC; Allen LA; Fonarow GC JACC Heart Fail; 2024 Aug; 12(8):1365-1377. PubMed ID: 38597866 [TBL] [Abstract][Full Text] [Related]
24. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure. Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690 [TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333 [TBL] [Abstract][Full Text] [Related]
26. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978 [TBL] [Abstract][Full Text] [Related]
27. Time to Triple Therapy in Patients With de Novo Heart Failure With Reduced Ejection Fraction: a Population-Based Study. Sepehrvand N; Nabipoor M; Youngson E; McAlister FA; Ezekowitz JA J Card Fail; 2023 May; 29(5):719-729. PubMed ID: 36754252 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. Smith KV; Dunning JR; Fischer CM; MacLean TE; Bosque-Hamilton JW; Fera LE; Grant JY; Zelle DJ; Matta L; Gaziano TA; MacRae CA; Scirica BM; Desai AS J Pharm Pract; 2022 Oct; 35(5):747-751. PubMed ID: 33813934 [TBL] [Abstract][Full Text] [Related]
30. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis. Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783 [TBL] [Abstract][Full Text] [Related]
31. Characteristics Associated with Upper-Range Doses of Beta-Blockers and Angiotensin-Renin Inhibitors in Reduced Ejection Fraction. Itzhaki Ben Zadok O; Murninkas D; Iakobishvili Z; Jino H; Yohananov E; Birkenfeld S; Hasdai D Isr Med Assoc J; 2020 Jul; 22(7):441-445. PubMed ID: 33236570 [TBL] [Abstract][Full Text] [Related]
32. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure. Nochioka K; Sakata Y; Shimokawa H Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073 [TBL] [Abstract][Full Text] [Related]
33. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015. Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404 [TBL] [Abstract][Full Text] [Related]
34. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry. Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953 [TBL] [Abstract][Full Text] [Related]
35. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure. Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181 [TBL] [Abstract][Full Text] [Related]
36. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827 [TBL] [Abstract][Full Text] [Related]
37. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice. Chin KL; Skiba M; Tonkin A; Reid CM; Liew D; Krum H; Hopper I Heart Fail Rev; 2016 Nov; 21(6):675-697. PubMed ID: 27465132 [TBL] [Abstract][Full Text] [Related]
38. Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol. Oyanguren J; García-Garrido L; Nebot Margalef M; Lekuona I; Comin-Colet J; Manito N; Roure J; Ruiz Rodriguez P; Enjuanes C; Latorre P; Torcal Laguna J; García-Gutiérrez S; ESC Heart Fail; 2017 Nov; 4(4):507-519. PubMed ID: 29154427 [TBL] [Abstract][Full Text] [Related]